Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 10, Number 11—November 2004

Research

Evaluating Human Papillomavirus Vaccination Programs

Al V. Taira*, Christopher P. Neukermans†, and Gillian D. Sanders†‡Comments to Author 
Author affiliations: *Stanford School of Medicine, Stanford, California, USA; †Stanford University, Stanford, California, USA; ‡Duke University, Durham, North Carolina, USA

Main Article

Figure A1

Prevalence of HPV-16 and HPV-18. A) HPV-16 prevalence in women. B) HPV-16 prevalence in men. C) HPV-18 prevalence in women. D) HPV-18 prevalence in men.

Figure A1. . Prevalence of HPV-16 and HPV-18. A) HPV-16 prevalence in women. B) HPV-16 prevalence in men. C) HPV-18 prevalence in women. D) HPV-18 prevalence in men.

Main Article

TOP